
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …

Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

